CN102834411B - 用于检测埃里希体属抗体的肽、装置和方法 - Google Patents

用于检测埃里希体属抗体的肽、装置和方法 Download PDF

Info

Publication number
CN102834411B
CN102834411B CN201080061669.1A CN201080061669A CN102834411B CN 102834411 B CN102834411 B CN 102834411B CN 201080061669 A CN201080061669 A CN 201080061669A CN 102834411 B CN102834411 B CN 102834411B
Authority
CN
China
Prior art keywords
peptide
amino acid
seq
acid selected
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201080061669.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN102834411A (zh
Inventor
R·K·梅拉
K·P·阿伦
D·M·布莱利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbess Co ltd
Zoetis Services LLC
Original Assignee
Abaxis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abaxis Inc filed Critical Abaxis Inc
Priority to CN201510582480.1A priority Critical patent/CN105203755B/zh
Publication of CN102834411A publication Critical patent/CN102834411A/zh
Application granted granted Critical
Publication of CN102834411B publication Critical patent/CN102834411B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/29—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Richettsiales (o)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN201080061669.1A 2009-11-20 2010-11-19 用于检测埃里希体属抗体的肽、装置和方法 Active CN102834411B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510582480.1A CN105203755B (zh) 2009-11-20 2010-11-19 用于检测埃里希体属抗体的肽、装置和方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26332909P 2009-11-20 2009-11-20
US61/263,329 2009-11-20
PCT/US2010/057430 WO2011063235A2 (en) 2009-11-20 2010-11-19 Peptides, devices, and methods for the detection of ehrlichia antibodies

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201510582480.1A Division CN105203755B (zh) 2009-11-20 2010-11-19 用于检测埃里希体属抗体的肽、装置和方法

Publications (2)

Publication Number Publication Date
CN102834411A CN102834411A (zh) 2012-12-19
CN102834411B true CN102834411B (zh) 2015-10-21

Family

ID=44060369

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201510582480.1A Active CN105203755B (zh) 2009-11-20 2010-11-19 用于检测埃里希体属抗体的肽、装置和方法
CN201080061669.1A Active CN102834411B (zh) 2009-11-20 2010-11-19 用于检测埃里希体属抗体的肽、装置和方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201510582480.1A Active CN105203755B (zh) 2009-11-20 2010-11-19 用于检测埃里希体属抗体的肽、装置和方法

Country Status (9)

Country Link
US (2) US8828675B2 (enExample)
EP (1) EP2501718B1 (enExample)
JP (2) JP6161291B2 (enExample)
KR (1) KR101892182B1 (enExample)
CN (2) CN105203755B (enExample)
AU (1) AU2010321790B2 (enExample)
CA (1) CA2781117C (enExample)
ES (1) ES2596952T3 (enExample)
WO (1) WO2011063235A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010321790B2 (en) 2009-11-20 2016-08-04 Zoetis Services Llc Peptides, devices, and methods for the detection of Ehrlichia antibodies
DK3489685T3 (da) * 2011-11-21 2023-12-04 Zoetis Services Llc Signalforstærkning i sidestrømning og tilsvarende immunoassays
CN105051541B (zh) 2012-10-11 2017-07-04 爱贝斯股份有限公司 用于检测埃里希体属抗体的肽、装置和方法
US9194870B2 (en) 2014-01-21 2015-11-24 Abaxis, Inc. Peptides, devices, and methods for the detection of Anaplasma antibodies
US9442112B2 (en) * 2014-04-04 2016-09-13 Abaxis, Inc. Compositions and methods for identifying Ehrlichia species
TWI691716B (zh) 2014-08-13 2020-04-21 美商艾巴希斯公司 電漿特異性結合搭配物檢定中之信號放大
CN104360058A (zh) * 2014-08-18 2015-02-18 石河子大学 一种新型检测人布鲁氏菌病抗体的免疫层析试纸及制备方法
JP6944438B2 (ja) 2015-08-04 2021-10-06 ゾエティス サービシズ リミテッド ライアビリティ カンパニー 溶液ベースのプラズモン特異的結合パートナーアッセイにおけるシグナル増幅
KR102654470B1 (ko) 2017-01-30 2024-04-05 조에티스 서비시즈 엘엘씨 용액-기반 플라스몬 특이적-결합 파트너 검정 및 금속성 나노구조체
JP2018128408A (ja) * 2017-02-10 2018-08-16 東ソー株式会社 抗体凝集体形成予測方法
US20180287426A1 (en) * 2017-03-30 2018-10-04 Qualcomm Incorporated Wireless power time division transmitter and coil array
US20190309422A1 (en) 2018-04-06 2019-10-10 Versum Materials Us, Llc Spin-On Metallization
JP2023546076A (ja) * 2020-10-08 2023-11-01 コントロールポイント インコーポレイテッド 呼吸器感染症を検出するための方法及び器具
CN112521463B (zh) * 2020-12-14 2023-08-04 杭州亿米诺生物科技有限公司 一种犬埃里希体MAP2-P30-gp19重组蛋白及其制备方法和应用
EP4220166A1 (en) 2022-02-01 2023-08-02 Universitat Rovira I Virgili (URV) In vitro method for detecting antibodies in a sample

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1735684A (zh) * 2002-11-04 2006-02-15 研究发展基金会 用于犬和人埃利希病的免疫诊断的p153和p156抗原及其用途
WO2009039414A2 (en) * 2007-09-21 2009-03-26 Idexx Laboratories, Inc. Methods and compositions for detection of ehrlichia chaffeensis (vlpt)

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
US6593147B1 (en) 1996-10-17 2003-07-15 University Of Florida Research Foundation, Inc. Nucleic acid vaccines against rickettsial diseases and methods of use
US6653128B2 (en) * 1996-10-17 2003-11-25 University Of Florida Nucleic acid vaccines against rickettsial diseases and methods of use
US6231869B1 (en) * 1997-03-21 2001-05-15 Corixa Corporation Compounds and methods for the diagnosis and treatment of ehrlichia infection
US6207169B1 (en) * 1997-03-21 2001-03-27 Corixa Corporation Compounds and methods for the diagnosis and treatment of Ehrlichia infection
DE69841037D1 (de) * 1997-04-25 2009-09-17 Antigenics Inc Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.
ATE481416T1 (de) 1997-09-19 2010-10-15 Univ Ohio State Res Found Proteine der äusseren membran von ehrlichia chaffeensis
US6043085A (en) * 1998-08-27 2000-03-28 Research Development Foundation Ehrlichia canis 120-kDa immunodominant antigenic protein and gene
US6893640B2 (en) * 1998-09-18 2005-05-17 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US7888491B2 (en) * 1998-09-18 2011-02-15 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US6544517B1 (en) * 1998-09-18 2003-04-08 The Ohio State University Research Foundation Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis
US6392023B1 (en) 1999-03-03 2002-05-21 Research Development Foundation Homologous 28-kilodalton immunodominant protein genes of Ehrlicha canis and uses thereof
CZ2002601A3 (cs) * 1999-07-21 2003-04-16 Cornell Research Foundation, Inc. Erlichia canis geny a vakcíny
US6355777B1 (en) 2000-04-28 2002-03-12 Research Development Foundation P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof
US7087372B2 (en) 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7407770B2 (en) * 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US7183060B2 (en) * 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US20030194756A1 (en) * 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
AU2002305159B2 (en) * 2001-03-28 2007-12-13 Heska Corporation Methods of detecting early renal disease in animals
US20030129161A1 (en) * 2001-09-17 2003-07-10 Hsien-Jue Chu Interleukin-12 as a veterinary vaccine adjuvant
US7482128B2 (en) * 2003-03-27 2009-01-27 Heska Corporation Anti-feline albumin antibodies
US7304139B2 (en) * 2003-10-28 2007-12-04 University Of Florida Research Foundation, Inc. Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same
US20060046310A1 (en) 2004-08-25 2006-03-02 Zong-Li Xia Amplification method for solid phase immunoassays
CA2604855C (en) * 2005-04-04 2016-11-01 Idexx Laboratories, Inc. Ehrlichia canis diva (differentiate infected from vaccinated animals)
US7842474B2 (en) * 2005-04-04 2010-11-30 Idexx Laboratories, Inc. Ehrlichia canis DIVA (differentiate infected from vaccinated animals)
EP1891095A2 (en) 2005-06-16 2008-02-27 Research Development Foundation Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis
US20090176208A1 (en) * 2006-01-04 2009-07-09 Simon Brodie Methods for detecting, identifying and reporting the presence of animal pathological agents
US7776618B2 (en) 2007-03-01 2010-08-17 Church & Dwight Co., Inc. Diagnostic detection device
US7507789B2 (en) * 2007-04-09 2009-03-24 Idexx Laboratories, Inc. Detection of Anaplasma platys
US8784828B2 (en) * 2007-05-04 2014-07-22 The Ohio State University Research Foundation Ehrlichia ewingii proteins, nucleic acids, and methods of their use
WO2009039413A2 (en) * 2007-09-21 2009-03-26 Idexx Laboratories, Inc. Methods and compositions for detection of ehrlichia chaffeensis (p120)
WO2009059170A2 (en) * 2007-10-31 2009-05-07 Idexx Laboratories, Inc. Ehrlichia canis diva (differentiate infection from vaccinated animals)
AU2010321790B2 (en) 2009-11-20 2016-08-04 Zoetis Services Llc Peptides, devices, and methods for the detection of Ehrlichia antibodies
CN105051541B (zh) 2012-10-11 2017-07-04 爱贝斯股份有限公司 用于检测埃里希体属抗体的肽、装置和方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1735684A (zh) * 2002-11-04 2006-02-15 研究发展基金会 用于犬和人埃利希病的免疫诊断的p153和p156抗原及其用途
WO2009039414A2 (en) * 2007-09-21 2009-03-26 Idexx Laboratories, Inc. Methods and compositions for detection of ehrlichia chaffeensis (vlpt)

Also Published As

Publication number Publication date
AU2010321790B2 (en) 2016-08-04
KR101892182B1 (ko) 2018-08-24
ES2596952T3 (es) 2017-01-13
CN105203755B (zh) 2018-01-05
CN102834411A (zh) 2012-12-19
US20150024417A1 (en) 2015-01-22
AU2010321790A1 (en) 2012-07-05
US8828675B2 (en) 2014-09-09
JP2013511546A (ja) 2013-04-04
EP2501718A2 (en) 2012-09-26
CA2781117C (en) 2019-05-28
US9470682B2 (en) 2016-10-18
EP2501718A4 (en) 2014-02-19
WO2011063235A2 (en) 2011-05-26
JP6161291B2 (ja) 2017-07-12
WO2011063235A3 (en) 2011-10-13
US20110124125A1 (en) 2011-05-26
KR20120117778A (ko) 2012-10-24
CA2781117A1 (en) 2011-05-26
CN105203755A (zh) 2015-12-30
EP2501718B1 (en) 2016-07-27
JP2016175908A (ja) 2016-10-06

Similar Documents

Publication Publication Date Title
CN102834411B (zh) 用于检测埃里希体属抗体的肽、装置和方法
US10948487B2 (en) Peptides, devices, and methods for the detection of Ehrlichia antibodies
JP2019048811A (ja) ライム病抗体の検出のためのペプチドおよび方法
CN102791727A (zh) 用于检测莱姆病抗体的肽和方法
CN105916518A (zh) 用于无形体属抗体的检测的肽、装置和方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: California, USA

Patentee after: Abbess Co.,Ltd.

Address before: California, USA

Patentee before: ABAXIS, Inc.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20210727

Address after: New Jersey USA

Patentee after: Zoetis Services LLC

Address before: California, USA

Patentee before: Abbess Co.,Ltd.